At a glance

How does Erythritol appear on a UK label?

Names to look forerythritol, E968
E-numberE968
Why it is usedBulk sweetening at roughly 60–70% of sucrose’s sweetness, with negligible calories.
Common inSugar-free and “no added sugar” chocolate, drinks, baked goods and chewing gum, often blended with stevia or monk fruit.

Useful label-reading detail

Look for erythritol or E968 in the ingredient list and check whether the nutrition panel gives total polyol grams. Unlike sorbitol, xylitol and maltitol, most erythritol does not reach the colon, so it tends to cause fewer digestive effects at an equivalent gram amount, though the UK laxative-effect warning threshold for polyols as a family still applies.

How it is classified

A polyol (sugar alcohol) sweetener. It is FODMAP-relevant mainly at higher doses, since most of it is absorbed before reaching the colon; it is not an emulsifier.

Why amount matters

EFSA’s 2023 acceptable daily intake is 0.5 g/kg body weight per day, a new numerical limit; EFSA’s own exposure modelling found high-consuming children and adolescents can exceed it, mainly through combined intake across several products rather than one serving. Older controlled tolerance studies found single or repeated doses up to around 0.66–1 g/kg body weight were tolerated without gastrointestinal symptoms in healthy adults, so general adult tolerance and the newer formal safety limit are not the same measurement.

Evidence by study type

What do studies show about Erythritol?

Metabolomic cohort study plus mechanistic and pilot data

What was studied: Witkowski et al. (2023) found associations between blood erythritol and three-year cardiovascular events in a discovery cohort (1,157 people) and two validation cohorts (2,149 and 833 people), alongside platelet experiments and a small pilot where 8 healthy volunteers drank an erythritol-sweetened beverage.

What it cannot tell us: The cohorts measured blood erythritol, not dietary intake, so dietary and metabolically produced erythritol could not be separated; the pilot arm had only 8 participants and measured plasma levels, not cardiovascular outcomes.

Sources2023 erythritol cardiovascular study

What human studies show about Erythritol

A human dose-ranging study found erythritol absorption from the small intestine is dose-dependent and largely complete at typical single doses, unlike xylitol which is poorly absorbed; a small proportion converts to erythronate, an effect not yet linked to a clear health outcome. An earlier controlled crossover study found repeated daily doses up to 1 g/kg body weight for a week were tolerated by 12 healthy adults without gastrointestinal intolerance, though EFSA’s 2023 review still set a lower formal daily intake threshold as a general safety margin.

SourcesPolyol systematic review2022 erythritol absorption studyEFSA erythritol re-evaluation2023 erythritol cardiovascular studyUK approved-additives listGreat Britain food-additive register

What animal or laboratory studies suggest about Erythritol

The same study included cell and animal experiments showing erythritol can increase platelet clumping and clot formation at concentrations the authors used to trigger the effect — concentrations far higher than those reached in its own small human pilot arm after a normal sweetened drink. Because most erythritol is absorbed rather than fermented, its digestive-symptom mechanisms differ from other polyols. The proposed cardiovascular mechanism relies on experimental platelet-activating concentrations, and EFSA’s own 2023 review stated that current evidence does not demonstrate a cause-and-effect relationship between erythritol consumption and cardiovascular disease risk.

SourcesPolyol systematic review2022 erythritol absorption studyEFSA erythritol re-evaluation2023 erythritol cardiovascular studyUK approved-additives listGreat Britain food-additive register

What we still do not know about Erythritol

Whether the blood-erythritol/cardiovascular association reflects dietary erythritol, the body’s own erythritol production linked to metabolic disease, or both, is not yet resolved. No trial has tested whether reducing dietary erythritol changes cardiovascular outcomes.

Great Britain regulatory context

E968 is authorised in Great Britain. EFSA’s 2023 re-evaluation set a new acceptable daily intake of 0.5 g/kg body weight per day, having previously considered no numerical limit necessary; it found estimated exposure in high-consuming children and adolescents can exceed it, rejected an industry request to remove the standard “excessive consumption may produce laxative effects” warning, and stated that current evidence does not demonstrate a cause-and-effect relationship between erythritol and cardiovascular disease risk.

SourcesPolyol systematic review2022 erythritol absorption studyEFSA erythritol re-evaluation2023 erythritol cardiovascular studyUK approved-additives listGreat Britain food-additive register

Common questions

Questions people ask about this label

Why is erythritol usually better tolerated than other polyols?

Unlike sorbitol, maltitol and xylitol, most erythritol is absorbed in the small intestine and passes out in urine rather than reaching the colon to be fermented. Less unabsorbed erythritol reaching the colon generally means less of the osmotic and gas-producing effect that drives symptoms with other polyols.

SourcesPolyol systematic review2022 erythritol absorption study

Does the 2023 heart-risk study mean erythritol is dangerous to eat?

The study found an association between blood erythritol levels and cardiovascular events, plus lab evidence that erythritol can affect platelets at high concentrations. It measured blood levels rather than diet, could not separate dietary erythritol from the body’s own production, and used platelet-activating concentrations well above typical intake. EFSA’s own 2023 review concluded current evidence does not show a cause-and-effect relationship between erythritol and cardiovascular disease. It is a signal worth further research, not proof that typical dietary erythritol causes heart problems.

Sources2023 erythritol cardiovascular studyEFSA erythritol re-evaluation

Has the safety limit for erythritol changed recently?

Yes. EFSA’s 2023 re-evaluation set a new acceptable daily intake of 0.5 g/kg body weight per day, a change from its earlier position that no numerical limit was needed. EFSA also found that high-consuming children and adolescents can exceed this new limit and kept the standard laxative-effect warning requirement in place.

SourcesEFSA erythritol re-evaluation

Can erythritol still cause bloating or a laxative effect?

Yes, particularly at higher single doses, since a small unabsorbed fraction still reaches the colon. Tolerance studies show good tolerance for most adults well above typical single servings, but individual sensitivity varies and repeated servings across a day can add up.

Sources2022 erythritol absorption studyPolyol systematic review

References

Sources used for this page

  1. Lenhart and Chey (2017), Systematic review of polyols and gastrointestinal health
  2. Bordier et al. (2022), Absorption and metabolism of the natural sweeteners erythritol and xylitol in humans: a dose-ranging study
  3. EFSA FAF Panel (2023), Re-evaluation of erythritol (E 968) as a food additive
  4. Witkowski et al. (2023), The artificial sweetener erythritol and cardiovascular event risk
  5. Food Standards Agency, Approved additives and E numbers
  6. Food Standards Agency, Register of food-additive authorisations for Great Britain

Written and evidence-checked by the GutGuard editorial team. We favour official UK guidance, systematic reviews and primary human research, and label animal, laboratory and exploratory findings clearly. Read our editorial method.